Heat shock protein 90 (HSP90) is secreted by cancer cells into the extracellular milieu, where it exerts pro-tumoral activities by activating extracellular substrate proteins and triggering autocrine signals through cancer cell surface receptors. Emerging evidence indicates that HSP90 co-chaperones are also secreted and may direct HSP90 extracellular activities. In this study, we found that the HSP90 co-chaperone Morgana is released by cancer cells and, in association with HSP90, induces cancer cell migration through TLR2, TLR4, and LRP1. In syngeneic cancer mouse models, a monoclonal antibody targeting Morgana extracellular activity reduced primary tumor growth via macrophage-dependent recruitment of CD8+ T lymphocytes, blocked cancer cell migration, and inhibited metastatic spreading. Overall, this data defines Morgana as a new player in the HSP90 extracellular interactome and suggests that Morgana may regulate HSP90 activity to promote cancer cell migration and suppress anti-tumor immunity.
Targeting the extracellular HSP90 co-chaperone Morgana inhibits cancer cell migration and promotes anti-cancer immunity
Seclì, LauraFirst
;Avalle, Lidia;Poggio, Pietro;Fragale, Giuseppe;Cannata, Cristiana;Conti, Laura;Carrà, Giovanna;Rubinetto, Cristina;Miniscalco, Barbara;Hirsch, Emilio;Poli, Valeria;Morotti, Alessandro;De Andrea, Marco;Turco, Emilia;Cavallo, Federica;Fusella, Federica;Brancaccio, Mara
Last
2021-01-01
Abstract
Heat shock protein 90 (HSP90) is secreted by cancer cells into the extracellular milieu, where it exerts pro-tumoral activities by activating extracellular substrate proteins and triggering autocrine signals through cancer cell surface receptors. Emerging evidence indicates that HSP90 co-chaperones are also secreted and may direct HSP90 extracellular activities. In this study, we found that the HSP90 co-chaperone Morgana is released by cancer cells and, in association with HSP90, induces cancer cell migration through TLR2, TLR4, and LRP1. In syngeneic cancer mouse models, a monoclonal antibody targeting Morgana extracellular activity reduced primary tumor growth via macrophage-dependent recruitment of CD8+ T lymphocytes, blocked cancer cell migration, and inhibited metastatic spreading. Overall, this data defines Morgana as a new player in the HSP90 extracellular interactome and suggests that Morgana may regulate HSP90 activity to promote cancer cell migration and suppress anti-tumor immunity.File | Dimensione | Formato | |
---|---|---|---|
Seclì et al., Cancer Research 2021 and supp.pdf
Accesso riservato
Descrizione: articolo completo
Tipo di file:
PDF EDITORIALE
Dimensione
3.68 MB
Formato
Adobe PDF
|
3.68 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Alla Commissione Ricerca del Senato Accademico.pdf
Accesso riservato
Descrizione: deroga
Tipo di file:
DEROGA (OBBLIGATORIO ALLEGARE FILE CON MOTIVAZIONE)
Dimensione
177.23 kB
Formato
Adobe PDF
|
177.23 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.